Abstract
This chapter summarizes the current state of knowledge and recent updates in the pathogenesis, diagnosis, and management of benign salivary gland neoplasms. Recent advances in genomics have provided additional insights into genomic events that drive benign salivary gland neoplasm development. The World Health Organization classification of benign salivary neoplasms was recently updated in 2017 to encompass additional entities. The Milan System for Reporting Salivary Gland Pathology provides standardization of fine-needle aspiration reporting and has important implications for improving the diagnosis and management of salivary gland neoplasms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
